
Case Report
Cancer Commons is collaborating with Cureus to bring you the first Exceptional Responders in Oncology Publishing Competition. We are seeking challenging cases in which patients exhibited unexpected or exceptional responses (positive or negative) to therapy.
We are particularly interested in the treatment options you considered, your clinical/scientific rationale for selecting the treatment, and the patient outcome. Our goal is to share the results with other patients and oncologists who might benefit, so that positive experiences can be quickly explored and negative experiences quickly avoided.
The entry period is now closed. Competition entries appear below as they are published. Now is your chance to score and discuss these articles. Remember, the article with the highest SIQ score will be chosen as the competition winner!
Eligible entries are limited to individual patient case reports, submitted and formatted via the template-driven, self-publishing Cureus platform. Case reports should aim for a 1,000 – 1,200 word target, with a 2,500 word maximum. A limit of five references is strongly encouraged (10 reference maximum).
Competition entry and case report submission is entirely free. All submitted work must be previously unpublished. For additional information on publishing with Cureus, please see our Author Guide.
Statement of Independence
Other Stipulations
A single $3,000 USD monetary prize will be awarded to the published case report that receives the highest Cureus SIQ™ (Scholarly Impact Quotient™) score. SIQ is Cureus’ unique post-publication peer-review process used to judge article importance via the collective intelligence of the Cureus community-at-large. The SIQ algorithm measures community engagement and scoring for article clarity and rationale, clinical importance, study design and methods, data analysis, novelty of conclusions and quality of presentation.
Eligible case reports must receive a minimum of 20 scores. (A Cureus user can assign only one score per article.) As engagement and scoring is critical to winning, authors are highly encouraged to share their published articles via social media and email.
To ensure that submitted work receives the exposure it deserves, all case reports published as part of this competition will be indexed in PubMed Central and distributed to large communities of oncologists around the globe.
We’ve assembled a world-class peer review panel to review all submitted case reports. Click on a reviewer name to learn more.
Article analysis and commentary performed by the peer review panel are strictly independent of the sponsor.